Effect of oral l-Glutamine supplementation on Covid-19 treatment
2020 · Clinical Nutrition Experimental · 77 citations
https://doi.org/10.1016/j.yclnex.2020.07.003
E
Erkan Özcan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
295
Citations
8
h-index
7
i10-index
Erkan Özcan is an academic researcher from Kastamonu University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Breast Cancer Treatment Studies. The author has an h-index of 8, co-authored 38 publications.
ORCID: 0000-0003-1562-6340Papers by this author
worksEndocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis
2025 · Medicina · 8 citations
https://doi.org/10.3390/medicina61010123
Understanding of Clinical Trials Among Patients With Cancer and Their Relatives
2025 · JAMA Network Open · 6 citations
https://doi.org/10.1001/jamanetworkopen.2024.57020
The co-presence of deletion 7q, 20q and inversion 16 in therapy-related acute myeloid leukemia developed secondary to treatment of breast cancer with cyclophosphamide, doxorubicin, and radiotherapy: a case report
2012 · Journal of Medical Case Reports · 4 citations
https://doi.org/10.1186/1752-1947-6-67
Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)
2024 · European Archives of Oto-Rhino-Laryngology · 4 citations
https://doi.org/10.1007/s00405-024-08744-4
Prognostic significance of HER2 loss after HER2-targeted neoadjuvant treatment in patients with HER2-positive locally advanced breast cancer
2024 · Current Problems in Cancer · 3 citations
https://doi.org/10.1016/j.currproblcancer.2024.101102
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat